321
person
Erik Roberson, MD, PhD
Erik Roberson, MD, PhD, is a physician-scientist with a focus on age-related neurodegenerative di
seases.
+ Read More
person
Bruce Miller, MD
Bruce Miller, MD, holds the A.W.
person
Stephen J. Haggarty, PhD
Stephen J.
person
David Siemer
David Siemer is the Co-Founder and CEO of Wave Digital Assets as well as the founder of Wavemaker
Partners and Wavemaker Genesis. Wavemaker includes seven funds with an AUM of $300m in the US and Southeast Asia which have all posted top-decile returns.
+ Read More
person
Ivan Soto-Wright
Soto-Wright is a leading financial technology entrepreneur and investor. Throughout his career, h
e has advocated for building systems and developing technologies that increase financial freedom.
+ Read More
person
Megan B. Miller, PhD
Megan B. Miller, PhD, is a socially minded neuroscientist with a passion for brain health advocac
y and strategic planning.
+ Read More
person
Megan van der Horst, PhD
Megan van der Horst, PhD, was an associate from 2021 to 2022 at the Milken Institute Center for S
trategic Philanthropy. She worked on the Center’s biomedical team, where she conducted research into ALS scientific and funding landscapes.
+ Read More
person
Justin Sun
report
Food and Agriculture in Asia: Investing in Resilience, Health, and Sustainability
As the world reels from multiple crises in rapid succession, the opportunities to set food systems
on a more sustainable and equitable path have never been more favorable, and in turn, the importance of multi-stakeholder convenings cannot be understated
+ Read More
report
Shared Responsibility: The Future of Green Financing
As the demand for green financing gains momentum, so too does the demand for complementary and prox
y industries, standards, and regulatory frameworks.
+ Read More
report
A Call to Action for Health Equity: Solutions from the Front Lines for Local and National Efforts
FasterCures is advancing system change within biomedical research to focus on and value diversity a
nd representation within clinical trials and the workforce.
+ Read More